publication venue for
- Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”. 28:107602962210788-107602962210788. 2022
- Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial. 28:107602962110739-107602962110739. 2022
- Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study. 26:107602962096222-107602962096222. 2020
- Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism. 25:107602961985362-107602961985362. 2019
- Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics. 25:107602961986205-107602961986205. 2019
- A Practical Guide to the Management of the Fetus and Newborn With Hemophilia. 24:29S-41S. 2018
- Incidence and Management of Thrombotic and Thromboembolic Complications Following the Superior Cavopulmonary Anastomosis Procedure: A Literature Review. 24:405-415. 2018
- Bridge Therapy Outcomes in Patients With Mechanical Heart Valves. 23:1036-1041. 2017
- Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review. 23:911-921. 2017
- Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice. 22:138-146. 2016
- Portal Vein Thrombosis. 20:498-506. 2014
- Thrombosis and Thromboembolic Complications in Fontan Patients. 20:484-492. 2014
- Venous Thromboembolism in Patients With Prior Stroke. 20:43-49. 2014
- Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates. 19:488-493. 2013
- Combined Modalities in Surgical Patients. 19:177-177. 2013
- Cost-Effectiveness of Prevention and Treatment of VTE. 19:225-229. 2013
- Critical Care Medical Patients. 19:171-172. 2013
- Diagnosis and Anticoagulant Treatment. 19:187-198. 2013
- General, Vascular, Bariatric, and Plastic Surgical Patients. 19:122-133. 2013
- Gynecology and Obstetrics. 19:135-141. 2013
- Heparin-Induced Thrombocytopenia. 19:208-214. 2013
- Inferior Vena Cava Filters. 19:204-205. 2013
- Introduction. 19:118-120. 2013
- Medical Patients. 19:163-171. 2013
- Neurosurgery. 19:161-163. 2013
- Orthopedic Surgery and Trauma. 19:141-160. 2013
- Patients With Cancer. 19:172-176. 2013
- Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation. 19:221-225. 2013
- Prevention of Postthrombotic Syndrome. 19:219-221. 2013
- Superficial Vein Thrombosis. 19:214-218. 2013
- Surgical Thrombectomy. 19:205-206. 2013
- The Problem and the Need for Prevention. 19:121-122. 2013
- Thrombolytic Therapy. 19:198-204. 2013
- Thrombophilia. 19:177-187. 2013
- Treatment for Patients With Cancer. 19:206-208. 2013
- Urologic Surgery. 19:133-134. 2013
- Dabigatran-Induced Acute Hepatitis. 18:549-550. 2012
- Immune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair Hemostasis. 17:620-632. 2011
- The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy. 17:E106-E113. 2011
- Safety and Efficacy of Thrombin-JMI: A Multidisciplinary Expert Group Consensus. 17:39-45. 2011
- The United States Food and Drugs Administration Approves a Generic Enoxaparin. 17:5-8. 2011
- Rivaroxaban in Orthopedic Surgery — A Change of Paradigm?. 15:613-620. 2009
- Dabigatran Etexilate: Future Directions in Anticoagulant Treatment. 15:32S-41S. 2009
- State-of-the-Art-Review : Statins Induce Hypothrombotic States?. 6:18-21. 2000
- Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism?. 3:S64-S67. 1997
- Familial Thrombophilia: A Review Analysis. 2:227-236. 1996